128 related articles for article (PubMed ID: 17886066)
1. Enhanced lung tumor development in tobacco smoke-exposed p53 transgenic and Kras2 heterozygous deficient mice.
Yan Y; Tan Q; Wang Y; Wang D; Jin M; Gordon T; Lubet RA; You M
Inhal Toxicol; 2007; 19 Suppl 1():183-7. PubMed ID: 17886066
[TBL] [Abstract][Full Text] [Related]
2. K-ras mutations in lung tumors from p53 mutant mice exposed to cigarette smoke.
Yao R; Wang Y; D'Agostini F; Izzotti A; Lubet RA; You M; De Flora S
Exp Lung Res; 2005 Mar; 31(2):271-81. PubMed ID: 15824025
[TBL] [Abstract][Full Text] [Related]
3. Molecular alterations and lung tumors in p53 mutant mice exposed to cigarette smoke.
De Flora S; Balansky RM; D'Agostini F; Izzotti A; Camoirano A; Bennicelli C; Zhang Z; Wang Y; Lubet RA; You M
Cancer Res; 2003 Feb; 63(4):793-800. PubMed ID: 12591728
[TBL] [Abstract][Full Text] [Related]
4. Gene expression in the lung of p53 mutant mice exposed to cigarette smoke.
Izzotti A; Cartiglia C; Longobardi M; Bagnasco M; Merello A; You M; Lubet RA; De Flora S
Cancer Res; 2004 Dec; 64(23):8566-72. PubMed ID: 15574763
[TBL] [Abstract][Full Text] [Related]
5. Tobacco smoke-induced lung tumorigenesis in mutant A/J mice with alterations in K-ras, p53, or Ink4a/Arf.
Wang Y; Zhang Z; Lubet R; You M
Oncogene; 2005 Apr; 24(18):3042-9. PubMed ID: 15846305
[TBL] [Abstract][Full Text] [Related]
6. Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice.
Wang Y; Zhang Z; Kastens E; Lubet RA; You M
Cancer Res; 2003 Aug; 63(15):4389-95. PubMed ID: 12907609
[TBL] [Abstract][Full Text] [Related]
7. The carcinogenicity of environmental tobacco smoke.
Witschi H; Espiritu I; Peake JL; Wu K; Maronpot RR; Pinkerton KE
Carcinogenesis; 1997 Mar; 18(3):575-86. PubMed ID: 9067559
[TBL] [Abstract][Full Text] [Related]
8. The complexities of an apparently simple lung tumor model: The A/J mouse.
Witschi H
Exp Toxicol Pathol; 2005 Jul; 57 Suppl 1():171-81. PubMed ID: 16092725
[TBL] [Abstract][Full Text] [Related]
9. A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents taxol or adriamycin.
Zhang Z; Liu Q; Lantry LE; Wang Y; Kelloff GJ; Anderson MW; Wiseman RW; Lubet RA; You M
Cancer Res; 2000 Feb; 60(4):901-7. PubMed ID: 10706103
[TBL] [Abstract][Full Text] [Related]
10. Farnesyltransferase inhibitors are potent lung cancer chemopreventive agents in A/J mice with a dominant-negative p53 and/or heterozygous deletion of Ink4a/Arf.
Zhang Z; Wang Y; Lantry LE; Kastens E; Liu G; Hamilton AD; Sebti SM; Lubet RA; You M
Oncogene; 2003 Sep; 22(40):6257-65. PubMed ID: 13679864
[TBL] [Abstract][Full Text] [Related]
11. A mouse lung tumor model of tobacco smoke carcinogenesis.
Witschi H; Espiritu I; Dance ST; Miller MS
Toxicol Sci; 2002 Aug; 68(2):322-30. PubMed ID: 12151628
[TBL] [Abstract][Full Text] [Related]
12. Lung tumors in A/J mice exposed to environmental tobacco smoke: estimated potency and implied human risk.
Bogen KT; Witschi H
Carcinogenesis; 2002 Mar; 23(3):511-9. PubMed ID: 11895867
[TBL] [Abstract][Full Text] [Related]
13. The carcinogenic potential of the gas phase of environmental tobacco smoke.
Witschi H; Espiritu I; Maronpot RR; Pinkerton KE; Jones AD
Carcinogenesis; 1997 Nov; 18(11):2035-42. PubMed ID: 9395199
[TBL] [Abstract][Full Text] [Related]
14. Wildtype Kras2 can inhibit lung carcinogenesis in mice.
Zhang Z; Wang Y; Vikis HG; Johnson L; Liu G; Li J; Anderson MW; Sills RC; Hong HL; Devereux TR; Jacks T; Guan KL; You M
Nat Genet; 2001 Sep; 29(1):25-33. PubMed ID: 11528387
[TBL] [Abstract][Full Text] [Related]
15. Cancer chemopreventive activity of a mixture of Chinese herbs (antitumor B) in mouse lung tumor models.
Zhang Z; Wang Y; Yao R; Li J; Yan Y; La Regina M; Lemon WL; Grubbs CJ; Lubet RA; You M
Oncogene; 2004 May; 23(21):3841-50. PubMed ID: 15021904
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of tobacco-smoke lung carcinogenesis in mice after cessation of smoke exposure.
Witschi H; Uyeminami D; Moran D; Espiritu I
Carcinogenesis; 2000 May; 21(5):977-82. PubMed ID: 10783321
[TBL] [Abstract][Full Text] [Related]
17. Use of p53 transgenic mice in the development of cancer models for multiple purposes.
Lubet RA; Zhang Z; Wiseman RW; You M
Exp Lung Res; 2000 Dec; 26(8):581-93. PubMed ID: 11195457
[TBL] [Abstract][Full Text] [Related]
18. Histological alterations in male A/J mice following nose-only exposure to tobacco smoke.
Hamm JT; Yee S; Rajendran N; Morrissey RL; Richter SJ; Misra M
Inhal Toxicol; 2007 May; 19(5):405-18. PubMed ID: 17365046
[TBL] [Abstract][Full Text] [Related]
19. Lung-specific expression of dominant-negative mutant p53 in transgenic mice increases spontaneous and benzo(a)pyrene-induced lung cancer.
Tchou-Wong KM; Jiang Y; Yee H; LaRosa J; Lee TC; Pellicer A; Jagirdar J; Gordon T; Goldberg JD; Rom WN
Am J Respir Cell Mol Biol; 2002 Aug; 27(2):186-93. PubMed ID: 12151310
[TBL] [Abstract][Full Text] [Related]
20. Evaluation on carcinogenicity of chemicals using transgenic mice.
Mitsumori K
Toxicology; 2002 Dec; 181-182():241-4. PubMed ID: 12505318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
